InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.470
+0.090 (3.78%)
May 15, 2026, 4:00 PM EDT - Market closed

InflaRx Revenue

InflaRx had revenue of 29.33K EUR in the twelve months ending March 31, 2026, down -77.39% year-over-year. In the year 2025, InflaRx had annual revenue of 29.33K, down -82.31%.

Revenue (ttm)
29.33K EUR
Revenue Growth
-77.39%
P/S Ratio
10,757.66
Revenue / Employee
451 EUR
Employees
65
Market Cap
363.81M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.33K-136.46K-82.31%
Dec 31, 2024165.79K102.70K162.79%
Dec 31, 202363.09K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology227.18M
Vanda Pharmaceuticals217.78M
Invivyd55.87M
Verastem49.59M
Opus Genetics11.98M
X4 Pharmaceuticals9.01M
YD Bio510.36K
Revenue Rankings